Safety and immunogenicity of full-dose quadrivalent influenza vaccine in children 6–35 months of age in China: A randomized, double-blind, clinical trial

Safety and immunogenicity of full-dose quadrivalent influenza vaccine in children 6–35 months of age in China: A randomized, double-blind, clinical trial

A half-dose influenza vaccine (7.5 μg hemagglutinin per strain) has been used for children under 3 years of age for a long time. However, several studies indicate that a full-dose influenza vaccine (15 μg hemagglutinin per strain) may bring more benefit to this population without increasing the risk...

Full description

Saved in:
Bibliographic Details
Main Authors: Shilei Wang, Yanxia Wang, Dandan Chen, Wenting Xu, Peng Duan, Wei Ji, Weijun Liu, Weijin Huang, Bing Wu, Wenqing Chai, Chenyan Zhao, Yongli Yang, Jian Luo, Dongyang Zhao, Xiuling Li
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Quadrivalent influenza vaccine
full-dose
clinical trails
6–35 months
safety
immunogenicity
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2425149
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items